Craniopharyngioma in Childhood

Advances in Pediatrics

Volumn 53, Issue 1, 2006, Pages 183-209

  May, Joshua A ^a   Krieger, Mark D ^b   Bowen, Ira ^a   Geffner, Mitchell E ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; WNT PROTEIN;

CHILD; CRANIOPHARYNGIOMA; GENETICS; HUMAN; HYPOPHYSIS TUMOR; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MULTIMODALITY CANCER THERAPY; OBESITY; PATHOPHYSIOLOGY; RADIATION DOSE; REVIEW;

CHILD; COMBINED MODALITY THERAPY; CRANIOPHARYNGIOMA; GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OBESITY; PITUITARY NEOPLASMS; RADIOTHERAPY DOSAGE; WNT PROTEINS;

EID: 33748971778     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2006.04.013     Document Type: Review

References (102)

1. Cushing H. Intracranial tumors. Notes upon a series of two thousand verified cases with surgical mortality percentages pertaining thereto (1932), Thomas, Springfield (IL)
2. DiPatri Jr. A.J., and Prabhu V. A history of the treatment of craniopharyngiomas. Childs Nerv Syst 21 (2005) 606-621
3. Ingraham F.D., and Scott H.W. Craniopharyngiomas in children. J Pediatr 29 (1946) 95-116
4. Matson D., and Crigler J. Management of craniopharyngioma in childhood. J Neurosurg 30 (1969) 377-390
5. Raimondi A.J., and Rougerie J. A critical review of personal experiences with craniopharyngioma: clinical history, surgical technique and operative results. 1983. Pediatr Neurosurg 21 (1994) 134-150
6. Lafferty A.R., and Chrousos G.P. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 84 (1999) 4317-4323
7. Kaatsch P., Rickert C.H., Kuhl J., et al. Population-based epidemiologic data on brain tumors in German children. Cancer 92 (2001) 3155-3164
8. Kuratsu J., and Ushio Y. Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto Prefecture, Japan. Pediatr Neurosurg 25 (1996) 240-246
9. Kadri H., Mawla A.A., and Murad L. Incidence of childhood brain tumors in Syria (1993-2002). Pediatr Neurosurg 41 (2005) 173-177
10. Rickert C.H., and Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 17 (2001) 503-511
11. Bunin G.R., Surawicz T.S., Witman P.A., et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg 89 (1998) 547-551
12. Miller D.C. Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg 21 Suppl 1 (1994) 11-17
13. Maitra A., and Abbas A. The endocrine system. In: Kumar V. (Ed). Robbins and Cotran: pathologic basis of disease (2005), Saunders, Philadelphia 1155-1226
14. Combelles G., Ythier H., Wemeau J.L., et al. Craniopharyngioma in the same family. Neurochirurgie 30 (1984) 347-349 [in French]
15. Boch A.L., Van Effenterre R., and Kujas M. Craniopharyngiomas in two consanguineous siblings: case report. Neurosurgery 41 (1997) 1185-1187
16. Green A.L., Yeh J.S., and Dias P.S. Craniopharyngioma in a mother and daughter. Acta Neurochir (Wien) 144 (2002) 403-404
17. Gorski G.K., McMorrow L.E., Donaldson M.H., et al. Multiple chromosomal abnormalities in a case of craniopharyngioma. Cancer Genet Cytogenet 60 (1992) 212-213
18. Yoshimoto M., de Toledo S.R., da Silva N.S., et al. Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. J Neurosurg 101 (2004) 85-90
19. Rickert C.H., and Paulus W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. J Neurol Neurosurg Psychiatry 74 (2003) 260-261
20. Sarubi J.C., Bei H., Adams E.F., et al. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes. Neurosci Lett 310 (2001) 5-8
21. Oikonomou E., Barreto D.C., Soares B., et al. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol 73 (2005) 205-209
22. Sekine S., Shibata T., Kokubu A., et al. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161 (2002) 1997-2001
23. Kato K., Nakatani Y., Kanno H., et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203 (2004) 814-821
24. Abrams L.S., and Repka M.X. Visual outcome of craniopharyngioma in children. J Pediatr Ophthalmol Strabismus 34 (1997) 223-228
25. Sklar C.A. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 21 Suppl 1 (1994) 18-20
26. Banna H., Hoare R.D., Stanley P., et al. Craniopharyngioma in children. J Pediatr 83 (1973) 781-785
27. Thomsett M.J., Conte F.A., Kaplan S.L., et al. Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 97 (1980) 728-735
28. de Vries L., Lazar L., and Phillip M. Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16 (2003) 703-710
29. Muller H.L., Emser A., Faldum A., et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89 (2004) 3298-3305
30. Gonzales-Portillo G., and Tomita T. The syndrome of inappropriate secretion of antidiuretic hormone: an unusual presentation for childhood craniopharyngioma: report of three cases. Neurosurgery 42 (1998) 917-921
31. Pollock A.N., Towbin R.B., Charron M., et al. Imaging in pediatric endcrine disorders. In: Sperling M.A. (Ed). Pediatric endocrinology (2002), Saunders, Philadelphia 731-738
32. Youl B.D., Plant G.T., Stevens J.M., et al. Three cases of craniopharyngioma showing optic tract hypersignal on MRI. Neurology 40 (1990) 1416-1419
33. Monzavi R., Kelly D.F., and Geffner M.E. Rathke's cleft cyst in two girls with precocious puberty. J Pediatr Endocrinol Metab 17 (2004) 781-785
34. Maat-Schieman M.L., Bots G.T., Thomeer R.T., et al. Malignant astrocytoma following radiotherapy for craniopharyngioma. Br J Radiol 58 (1985) 480-482
35. Yasargil M.G., Curcic M., Kis M., et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73 (1990) 3-11
36. Fischer E.G., Welch K., Shillito Jr. J., et al. Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 73 (1990) 534-540
37. Cavazzuti V., Fischer E.G., Welch K., et al. Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 59 (1983) 409-417
38. Sanford R.A. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 21 Suppl 1 (1994) 39-43
39. Albright A.I., Hadjipanayis C.G., Lunsford L.D., et al. Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst 21 (2005) 649-654
40. Mark R.J., Lutge W.R., Shimizu K.T., et al. Craniopharyngioma: treatment in the CT and MR imaging era. Radiology 197 (1995) 195-198
41. Arita N., Mori S., and Ikeda T. Removal of craniopharyngioma by a unilateral interhemispheric trans-lamina terminalis approach: operative procedures and postoperative management. In: Samii M. (Ed). Surgery in and around the brain stem and the third ventricle (1986), Springer-Verlag, Berlin 389-395
42. Baskin D.S., and Wilson C.B. Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg 65 (1986) 22-27
43. Hader W.J., Steinbok P., Hukin J., et al. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 33 (2000) 211-218
44. Mottolese C., Stan H., Hermier M., et al. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv Syst 17 (2001) 724-730
45. Savas A., Erdem A., Tun K., et al. Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46 (2000) 213-216
46. Zanon N. Bleomycin treatment of cystic cranipharyngioma. In: Choux M., diRocco C., and Hockley A. (Eds). Pediatric neurosurgery (1999), Churchill Livingstone, New York 541-542
47. Einhaus S.L., and Sanford R.A. Craniopharyngiomas. In: Albright A.L., Pollack I.F., and Adeleson P.D. (Eds). Principles and practice of pediatric neurosurgery (1999), Thieme, New York 545-562
48. Voges J., Sturm V., Lehrke R., et al. Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40 (1997) 263-269
49. Ulfarsson E., Lindquist C., Roberts M., et al. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 97 (2002) 613-622
50. Tomita T., and Bowman R.M. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Childs Nerv Syst 21 (2005) 729-746
51. Wara W.M., Sneed P.K., and Larson D.A. The role of radiation therapy in the treatment of craniopharyngioma. Pediatr Neurosurg 21 Suppl 1 (1994) 98-100
52. Regine W.F., Mohiuddin M., and Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 27 (1993) 13-21
53. Sung D.I., Chang C.H., Harisiadis L., et al. Treatment results of craniopharyngiomas. Cancer 47 (1981) 847-852
54. Kalapurakal J.A. Radiation therapy in the management of pediatric craniopharyngiomas-a review. Childs Nerv Syst 21 (2005) 808-816
55. Laws Jr. E.R., and Vance M.L. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 10 (1999) 327-336
56. Kalapurakal J.A., Ilahi Z., Kepka A.G., et al. Repositioning accuracy with the Laitinen frame for fractionated stereotactic radiation therapy in adult and pediatric brain tumors: preliminary report. Radiology 218 (2001) 157-161
57. Schulz-Ertner D., Frank C., Herfarth K.K., et al. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54 (2002) 1114-1120
58. Kooy H.M., Dunbar S.F., Tarbell N.J., et al. Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 30 (1994) 685-691
59. Tarbell N., Scott R.M., and Goumnerova L.C. Craniopharyngioma: preliminary results of stereotactic radiation therapy. In: Kondziolka D. (Ed). Radiosurgery (1996), Karger, Basel, Switzerland 75-82
60. Tishler R.B., Loeffler J.S., Lunsford L.D., et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27 (1993) 215-221
61. Tarbell N.J., Barnes P., Scott R.M., et al. Advances in radiation therapy for craniopharyngiomas. Pediatr Neurosurg 21 Suppl 1 (1994) 101-107
62. Austin-Seymour M., Munzenrider J., Linggood R., et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 13 (1990) 327-330
63. De Vile C.J., Grant D.B., Hayward R.D., et al. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81 (1996) 2734-2737
64. Fisher P.G., Jenab J., Gopldthwaite P.T., et al. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 14 (1998) 558-563
65. Khafaga Y., Jenkin D., Kanaan I., et al. Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 42 (1998) 601-606
66. Geffner M.E. Hypopituitarism in childhood. Cancer Control 9 (2002) 212-222
67. Geffner M.E., Lippe B.M., Bersch N., et al. Growth without growth hormone: evidence for a potent circulating human growth factor. Lancet 1 (1986) 343-347
68. Geffner M.E. The growth without growth hormone syndrome. Endocrinol Metab Clin North Am 25 (1996) 649-663
69. Costin G., Kogut M.D., Phillips L.S., et al. Craniopharyngioma: the role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 42 (1976) 370-379
70. Hogeveen M., Noordam C., Otten B., et al. Growth before and during growth hormone treatment in children operated for craniopharyngioma. Horm Res 48 (1997) 258-262
71. Geffner M., Lundberg M., Koltowska-Haggstrom M., et al. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89 (2004) 5435-5440
72. Niu D.M., Guo W.Y., Pan H.C., et al. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement. Childs Nerv Syst 18 (2002) 164-165
73. Clayton P.E., Price D.A., Shalet S.M., et al. Craniopharyngioma recurrence and growth hormone therapy. Lancet 1 (1988) 642
74. Moshang Jr. T., Rundle A.C., Graves D.A., et al. Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128 (1996) S4-S7
75. Price D.A., Wilton P., Jonsson P., et al. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 49 (1998) 91-97
76. Sosa I.J., Krieger M.D., and McComb J.G. Craniopharyngiomas of childhood: the CHLA experience. Childs Nerv Syst 21 (2005) 785-789
77. Curtis J., Daneman D., Hoffman H.J., et al. The endocrine outcome after surgical removal of craniopharyngiomas. Pediatr Neurosurg 21 Suppl 1 (1994) 24-27
78. Poretti A., Grotzer M.A., Ribi K., et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46 (2004) 220-229
79. Merchant T.E., Kiehna E.N., Sanford R.A., et al. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 53 (2002) 533-542
80. Gonc E.N., Yordam N., Ozon A., et al. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases. Pediatr Neurosurg 40 (2004) 112-119
81. Caldarelli M., Massimi L., Tamburrini G., et al. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst 21 (2005) 747-757
82. Schöfl C., Schleth A., Berger D., et al. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma. J Clin Endocrinol Metab 87 (2002) 624-629
83. Coutant R., Maurey H., Rouleau S., et al. Defect in epinephrine production in children with craniopharyngioma: functional or organic origin?. J Clin Endocrinol Metab 88 (2003) 5969-5975
84. Müller H.L., Handwerker G., Wollny B., et al. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87 (2002) 3993-3996
85. Lustig R.H. Hypothalmic obesity: the sixth cranial endocrinopathy. Endocrinologist 12 (2005) 210-217
86. Srinivasan S., Ogle G.D., Garnett S.P., et al. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89 (2004) 81-86
87. Brabant G., Horn R., Mayr B., et al. Serum leptin levels following hypothalamic surgery. Horm Metab Res 28 (1996) 728-731
88. Roth C., Wilken B., Hanefeld F., et al. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138 (1998) 89-91
89. Harz K.J., Muller H.L., Waldeck E., et al. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88 (2003) 5227-5231
90. Lustig R.H., Hinds P.S., Ringwald-Smith K., et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88 (2003) 2586-2592
91. Mason P.W., Krawiecki N., and Meacham L.R. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156 (2002) 887-892
92. Novegno F., Di Rocco F., Colosimo J.C., et al. Ectopic recurrences of craniopharyngioma. Childs Nerv Syst 18 (2002) 468-473
93. Gupta K., Kuhn M.J., Shevlin D.W., et al. Metastatic craniopharyngioma. AJNR Am J Neuroradiol 20 (1999) 1059-1060
94. Ito M., Jamshidi J., and Yamanaka K. Does craniopharyngioma metastasize? Case report and review of the literature. Neurosurgery 48 (2001) 933-935
95. Kranzinger M., Jones N., Rittinger O., et al. Malignant glioma as a secondary malignant neoplasm after radiation therapy for craniopharyngioma: report of a case and review of reported cases. Onkologie 24 (2001) 66-72
96. Colangelo M., Ambrosio A., and Ambrosio C. Neurological and behavioral sequelae following different approaches to craniopharyngioma. Long-term follow-up review and therapeutic guidelines. Childs Nerv Syst 6 (1990) 379-382
97. Carpentieri S.C., Waber D.P., Scott R.M., et al. Memory deficits among children with craniopharyngiomas. Neurosurgery 49 (2001) 1053-1057
98. Anderson C.A., Wilkening G.N., Filley C.M., et al. Neurobehavioral outcome in pediatric craniopharyngioma. Pediatr Neurosurg 26 (1997) 255-260
99. Riva D., Pantaleoni C., Devoti M., et al. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 14 (1998) 179-184
100. Merchant T.E., Gould C.J., Xiong X., et al. Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 58 (2004) 1194-1207
101. Bulow B., Attewell R., Hagmar L., et al. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 83 (1998) 3897-3904
102. Pereira A.M., Schmid E.M., Schutte P.J., et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 62 (2005) 197-204